908 Devices Inc News - MASS | ADVFN

Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

908 Devices Inc (MASS)

5.56

0.13

(2.39%)

Closed July 30 4:00PM

Delayed by 15 minutes

5.56

0.00

( 0.00% )

Pre Market: 7:01AM

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

SVB Securities Keeps Their Buy Rating on 908 Devices (MASS)

SVB Securities analyst Puneet Souda maintained a Buy rating on 908 Devices (MASS - Research Report) today and set a price target of $25.00. The...

Quarterly Report (10-q)

P1YP1YP1YP1Y0001555279--12-312022Q3false000000003160648427707858314416112744614931077004316520580.200.190.760.68P3MP3Mhttp://fasb.org/us-gaap/2021...

Current Report Filing (8-k)

0001555279 false 0001555279 2022-11-14 2022-11-14 iso4217:USD xbrli:shares...

908 Devices Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Outlook

Q3 2022 revenue increases 26% over prior year, with gross margin of 59% 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and...

908 Devices Records Strong Momentum in Life Sciences Sector

Driven by Biopharma 4.0, proteomics research and acquisition of TRACE Analytics, 908 Devices empowers more effective drug discoveries 908...

908 Devices Launches Pesticide Identification Capability to Thwart Illegal Marijuana Growing Operations

Developed in coordination with the U.S. Forest Service, the MX908 can identify toxic pesticides that pose...

908 Devices to Participate in Upcoming Investor Conferences

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

908 Devices to Report Third Quarter 2022 Financial Results on November 14, 2022

908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today...

908 Devices and CPI Improve mAbs Cell Culture Outcomes Using At-line Media Analysis

REBEL mass spec device used to reduce toxic metabolite accumulation while increasing cell viability and titer by up to 40% 908 Devices (Nasdaq:...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

SVB Securities Keeps Their Buy Rating on 908 Devices (MASS)

SVB Securities analyst Puneet Souda maintained a Buy rating on 908 Devices (MASS - Research Report) on August 9 and set a price target of $30.00...

Monksdream

Monksdream 5 months ago

MASS 10Q due March 5

Monksdream

Monksdream 12 months ago

From that awful Cathie Wood
908 Devices (MASS)
icon-rise-1
22%
Shares of 908 Devices traded up ~22% on Tuesday after the company released5 its second-quarter results in which revenues rose 9% on a year-over-year basis, surprising on the high side of expectations. 908 Devices is a life sciences tools company that miniaturizes mass spectrometry to decentralize chemical and biomolecular analyses.

Wolters Kluwers NV

Delayed Upgrade Clock